Chongqing, China

Yuyang Yi

USPTO Granted Patents = 2 


Average Co-Inventor Count = 27.4

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yuyang Yi - Innovator in Polyethylene Glycol Conjugate Drugs

Introduction

Yuyang Yi is a prominent inventor based in Chongqing, China. He has made significant contributions to the field of medicine, particularly in the development of polyethylene glycol conjugate drugs. With a total of two patents to his name, Yi's work is paving the way for advancements in pharmaceutical compositions.

Latest Patents

Yuyang Yi's latest patents include innovative formulations and methods related to polyethylene glycol conjugated drugs. The first patent focuses on a polyethylene glycol conjugate drug, detailing its preparation method and various uses. This invention is particularly relevant in the technical field of medicines, showcasing a novel approach to drug formulation. The second patent also pertains to a polyethylene glycol conjugate medicament, emphasizing its preparation method and applications in creating effective pharmaceutical compositions.

Career Highlights

Yuyang Yi is currently associated with Chongqing Upgra Biotechnology Co., Ltd., where he continues to explore and develop new medicinal technologies. His expertise in the field has led to significant advancements in drug development, particularly in the area of polyethylene glycol conjugates.

Collaborations

Yuyang Yi collaborates with notable colleagues, including Gaoquan Li and Dajun Li. These partnerships enhance the innovative potential of his research and contribute to the success of their projects.

Conclusion

Yuyang Yi's contributions to the field of medicine through his patents on polyethylene glycol conjugate drugs highlight his role as a key innovator. His work not only advances pharmaceutical science but also holds promise for future medical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…